Skip to Content

LOGO 200 (Nexavar 200 mg)

Generic Name: sorafenib

Pill imprint LOGO 200 has been identified as Nexavar 200 mg.

Nexavar is used in the treatment of hepatocellular carcinoma; hepatic tumor; renal cell carcinoma; thyroid cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Nexavar 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nexavar
Generic Name:
sorafenib
Imprint:
LOGO 200
Strength:
200 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Bayer HealthCare Pharmaceuticals Inc.
National Drug Code (NDC):
00026-8488

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide